undamentalytics Newsletter

The9 LTD (NCTY) stock

Add holding +

NASDAQ: NCTY Nasdaq Investment Banking & Brokerage

E Fundamentals grade

The9 LTD is a US-listed company in the investment banking & brokerage industry. Its financial year ends in December.

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Funds4 adding, 5 cuttingOf 1 active managers that changed their stake, 1 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter The9 files

Where The9 LTD stands after its latest Filing

Revenue for the twelve months was $15m, down 3.3% on a year earlier, a smaller fall than the 36.9% decline a quarter earlier. That puts it 35 of 40 for growth among the investment banking & brokerage companies we cover. The diluted share count is up 62.0% on a year earlier, which dilutes existing holders.

Our model value for The9 is under review, so past values are not shown until it is resolved.

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Where it stands out: change in growth rate of +33.6pp ranks 7 of 40 investment banking & brokerage companies we cover. Where it lags: stock pay as % of revenue of 107.6% ranks 36 of 36 investment banking & brokerage companies we cover.

Current signal Revenue growth accelerating: TTM revenue growth rose to -3.3% (+33.6pp vs the prior quarter).

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Strengths

  • Net cash. Cash exceeds long-term debt by $0.0bn.

Things to watch

  • Revenue shrinking. Revenue fell 3.3% over the last 12 months.
  • Loss-making. Operating margin is -260.5%: costs exceed revenue.
  • Margins narrowing. Operating margin is down 207.9 points on a year ago.
  • Burning cash. Free cash flow was -76.5% of revenue over the last 12 months.
  • Heavy stock-based pay. Stock pay equals 107.6% of revenue, against a median of 4.8% for investment banking & brokerage companies we cover: a real cost that cash-flow figures leave out.
  • Share dilution. Diluted shares rose 62.0% in a year.

Price chart

  • 1 day-10.7%
  • 1 week-18.6%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$15M
Operating margin
-260.5%
Net margin
-373.0%
EPS (TTM, diluted)
$-7.39

Growth

Revenue growth
−3.3%
Change in growth rate
+33.6 pts
Share count change
+62.0%

News & updates

Updated November 2, 2026

Company announcements, filed results and changes that matter to shareholders.

No recent updates are available for NCTY from the sources we follow. See filings →

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

No model value for The9 LTD at the moment. Current status: no valuation model gives a value we can rate yet. Available reported financials are shown below.

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: no valuation model gives a value we can rate yet.

The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.

Valuation models

We value The9 LTD as an asset manager, broker or exchange, with every model that fits that kind of business. Cost of equity 9.5%: the 10-year Treasury yield (4.9%) plus a beta of 1 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. — Does not apply: This model is withheld pending its input or assumption review.
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: This model is withheld pending its input or assumption review.
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: This model is withheld pending its input or assumption review.
Price-to-book vs peers Book value per share times peers' typical (harmonic-mean) price-to-book. ~$0.4 ~$4.3–$16 Left out: out of range vs price (0.13x)
Dividend discount (two-stage) Dividends for five years at the growth the business can fund, then a steady payout and growth. — Does not apply: This model is withheld pending its input or assumption review.
Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. — Combined value withheld. Review the individual models and their assumptions.

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare The9 LTD with brokers, investment banks and exchanges in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

No analyst estimates are published for The9 LTD: too few analysts cover it.

Positioning

Short interest
6.5%
of tradable shares
Days to cover
4.84
at average volume
Short interest, 1 month
+28%
to October 15, 2026
Held by institutions
0%
of shares
Held by insiders
17.4%
of shares
Employees
44
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Recent prices are available. Older price history and the statistics that need it are being loaded in the background.

Price behaviour

52-week range
Not enough history
From 52-week high
—
vs 50-day average
—
vs 200-day average
—
Volatility (1 year)
—
Beta vs S&P 500
—

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

The9 LTD in five measures

Fundamentals grade E
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) The9 LTD
$0 $10M $20M $30M FY14 Q4 FY17 Q4 FY20 Q4 FY25 Q4 Revenue (TTM), FY14 Q4: $10.5M Revenue (TTM), FY15 Q4: $7.4M Revenue (TTM), FY16 Q4: $8.5M Revenue (TTM), FY17 Q4: $10.8M Revenue (TTM), FY18 Q4: $2.7M Revenue (TTM), FY19 Q4: $49.5K Revenue (TTM), FY20 Q4: $90.7K Revenue (TTM), FY21 Q4: $21M Revenue (TTM), FY22 Q4: $15.6M Revenue (TTM), FY23 Q4: $24.6M Revenue (TTM), FY24 Q4: $15.5M Revenue (TTM), FY25 Q4: $15M $15M

Source: SEC EDGAR filings. Retrieved Invalid Date.

View chart data
Period Revenue (TTM)
FY14 Q4 $10.5M
FY15 Q4 $7.4M
FY16 Q4 $8.5M
FY17 Q4 $10.8M
FY18 Q4 $2.7M
FY19 Q4 $49.5K
FY20 Q4 $90.7K
FY21 Q4 $21M
FY22 Q4 $15.6M
FY23 Q4 $24.6M
FY24 Q4 $15.5M
FY25 Q4 $15M
Revenue growth, TTM YoY The9 LTD
-10000% 0% 10000% 20000% 30000% FY14 Q4 FY17 Q4 FY20 Q4 FY25 Q4 Revenue growth, TTM YoY, FY14 Q4: -39.3% Revenue growth, TTM YoY, FY15 Q4: -29.5% Revenue growth, TTM YoY, FY16 Q4: 14.3% Revenue growth, TTM YoY, FY17 Q4: 27.8% Revenue growth, TTM YoY, FY18 Q4: -75.5% Revenue growth, TTM YoY, FY19 Q4: -98.1% Revenue growth, TTM YoY, FY20 Q4: 83.3% Revenue growth, TTM YoY, FY21 Q4: 23083.4% Revenue growth, TTM YoY, FY22 Q4: -25.7% Revenue growth, TTM YoY, FY23 Q4: 57.4% Revenue growth, TTM YoY, FY24 Q4: -36.9% Revenue growth, TTM YoY, FY25 Q4: -3.3% -3.3%

Source: SEC EDGAR filings. Retrieved Invalid Date.

View chart data
Period Revenue growth, TTM YoY
FY14 Q4 -39.3%
FY15 Q4 -29.5%
FY16 Q4 14.3%
FY17 Q4 27.8%
FY18 Q4 -75.5%
FY19 Q4 -98.1%
FY20 Q4 83.3%
FY21 Q4 23083.4%
FY22 Q4 -25.7%
FY23 Q4 57.4%
FY24 Q4 -36.9%
FY25 Q4 -3.3%
Operating margin (TTM) The9 LTD
-50000% 0% 50000% 100000% FY14 Q4 FY17 Q4 FY20 Q4 FY25 Q4 Operating margin (TTM), FY14 Q4: -248.1% Operating margin (TTM), FY15 Q4: -700.5% Operating margin (TTM), FY16 Q4: -525.2% Operating margin (TTM), FY17 Q4: -154.8% Operating margin (TTM), FY18 Q4: -598.9% Operating margin (TTM), FY19 Q4: -47941.2% Operating margin (TTM), FY20 Q4: 53831.3% Operating margin (TTM), FY21 Q4: -226.9% Operating margin (TTM), FY22 Q4: -630.5% Operating margin (TTM), FY23 Q4: -182.6% Operating margin (TTM), FY24 Q4: -52.6% Operating margin (TTM), FY25 Q4: -260.5% -260.5%

Source: SEC EDGAR filings. Retrieved Invalid Date.

View chart data
Period Operating margin (TTM)
FY14 Q4 -248.1%
FY15 Q4 -700.5%
FY16 Q4 -525.2%
FY17 Q4 -154.8%
FY18 Q4 -598.9%
FY19 Q4 -47941.2%
FY20 Q4 53831.3%
FY21 Q4 -226.9%
FY22 Q4 -630.5%
FY23 Q4 -182.6%
FY24 Q4 -52.6%
FY25 Q4 -260.5%
FCF margin (TTM) The9 LTD
-1000% -500% 0% 500% FY13 Q4 FY15 Q4 FY17 Q4 FY21 Q4 FY23 Q4 FCF margin (TTM), FY13 Q4: -353.2% FCF margin (TTM), FY14 Q4: 390.9% FCF margin (TTM), FY15 Q4: -401.5% FCF margin (TTM), FY16 Q4: -332.4% FCF margin (TTM), FY17 Q4: -125.6% FCF margin (TTM), FY18 Q4: -599.4% FCF margin (TTM), FY21 Q4: -554.5% FCF margin (TTM), FY22 Q4: -233.9% FCF margin (TTM), FY23 Q4: -76.5% -76.5%

Source: SEC EDGAR filings. Retrieved Invalid Date.

View chart data
Period FCF margin (TTM)
FY13 Q4 -353.2%
FY14 Q4 390.9%
FY15 Q4 -401.5%
FY16 Q4 -332.4%
FY17 Q4 -125.6%
FY18 Q4 -599.4%
FY21 Q4 -554.5%
FY22 Q4 -233.9%
FY23 Q4 -76.5%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 20-F, 20-F/A. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

The9 LTD: annual financial statements
Fiscal year 2009 Dec 2009 2010 Dec 2010 2011 Dec 2011 2012 Dec 2012 2013 Dec 2013 2014 Dec 2014 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025
Income
Revenue 118 16 17 26 17 11 7 8 11 3 0 0 21 16 25 16 15
Gross profit 7 −0 10 13 −0 −3 −3 1 7 0 −0 −0 7 −7 −6 −0 0
EBITDA — — — — −83 −24 −50 −43 −16 −15 — — −40 −85 −33 — —
Operating income −71 −52 −59 −94 −86 −26 −52 −45 −17 −16 −24 49 −48 −99 −45 −8 −39
Net income −59 −74 −44 −81 −86 −17 −61 −89 −17 −33 −26 58 −64 −145 3 −10 −56
Diluted EPS — −$293.85 −$176.26 −$332.54 −$369.43 −$75.47 −$263.47 — — — −$25.92 $35.08 −$38.60 — $0.85 −$2.08 −$7.51
Growth (year on year)
Revenue — −86.4% +8.6% +49.0% −33.1% −39.3% −29.5% +14.3% +27.8% −75.5% −98.1% +83.3% +>999% −25.7% +57.4% −36.9% −3.3%
Operating income — — — — — — — — — — — — −197.7% — — — —
Net income — — — — — — — — — — — — −210.5% — — −461.0% —
Diluted EPS — — — — — — — — — — — — −210.1% — — −345.9% —
Margins
Gross margin 6.0% −0.4% 59.8% 52.0% −2.8% −33.2% −45.8% 13.6% 67.4% 5.7% −293.1% −30.2% 35.2% −45.2% −22.5% −1.4% 1.7%
EBITDA margin — — — — −479.4% −223.9% −675.7% −512.2% −147.5% −578.1% — — −191.9% −543.4% −132.7% — —
Operating margin −60.2% −326.0% −341.5% −362.1% −497.3% −248.1% −700.5% −525.2% −154.8% −598.9% <−999% >999% −226.9% −630.5% −182.6% −52.6% −260.5%
Net margin −50.5% −460.4% −252.8% −314.2% −493.6% −166.1% −825.2% <−999% −161.4% <−999% <−999% >999% −303.3% −929.1% 11.5% −65.7% −373.0%
Cash flow
Cash from operations −16 −37 −42 −78 −58 44 −28 −27 −13 −15 −8 −15 −109 −23 −7 −6 −4
Stock-based pay 10 4 8 6 5 1 5 4 6 1 3 8 23 30 10 6 16
Balance sheet
Cash 245 215 170 89 26 29 8 6 22 1 1 5 67 8 6 1 8
Total debt 0 0 0 0 0 0 21 44 — 71 76 0 15 9 9 — 32
Net debt (negative = net cash) −245 −215 −170 −89 −26 −29 13 38 −22 70 75 −5 −53 0 3 −1 23
Diluted shares — — — — — — — — — — 1m 2m 2m — 3m 5m 8m
Returned to shareholders
Dividends 29 0 0 — — — — — — — — — — — — — —
Buybacks 23 0 3 0 5 0 — — — — — — — — — — —
Total returned 52 0 3 0 5 0 — — — — — — — — — — —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Dividends, buybacks and capital spending

Diluted share count
+62.0%
year over year
R&D spending
9.1%
of revenue

Competitors: side by side with peers

Closest by revenue in investment banking & brokerage
Growth, margins and cash generation against peers
Last 12 months unless stated NCTY ARBK WTF LGHL AXG GSIW Median
Revenue, last 12 months $15m $16m $11m $9m $28m $7m $2.0bn
Revenue growth, last 12 months −3.3% −67.0% 48.8% 657.5% 895.0% 33.2% 20.7%
Gross margin 1.7% 1.8% — −392.5% — — 3.6%
Operating margin −260.5% −86.3% −131.1% −27.6% 0.1% — −2.3%
Net margin −373.0% 32.8% −136.7% −52.8% −47.4% −190.1% 5.8%
Cash from operations / revenue −29.4% −161.1% −63.7% −37.5% −54.7% −58.2% 7.7%
Free-cash-flow margin −76.5% −161.9% −66.6% −37.6% −55.3% −59.6% 5.2%
Stock pay / revenue 107.6% 17.1% 63.7% 2.3% 11.5% 62.2% 4.7%
Change in share count 62.0% 260.0% 15.4% 37.0% 674.4% 7.7% 1.2%

Median of all 40 companies we cover in investment banking & brokerage. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

40 investment banking & brokerage companies
Measures ranked against peers
Measure Company Peer median Rank
Revenue growth Growth -3.3% 20.8% 35 of 40
Change in growth rate Growth +33.6pp -0.3pp 7 of 40
Operating margin Profitability -260.5% -2.3% 15 of 17
Net margin Profitability -373.0% 6.0% 38 of 40
Stock pay as % of revenue Cash generation 107.6% 4.8% 36 of 36
Change in share count Balance sheet 62.0% 1.2% 29 of 35

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Reported value
$311,651
Institutions reporting
9
Shares held vs prior quarter
▲ 25.7%
Positions opened / closed
2 / 3

Top buyers and sellers, Q2 2026: 4 institutions bought and 5 sold ; the biggest buyer was Citadel Advisors LLC (+31K shares) and the biggest seller Jane Street Group, LLC (−15K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Citadel Advisors LLC $150,651 31K 48.3% New
HRT Financial LP $98,000 20K 31.4% ▲ 67.8%
Independent Advisor Alliance $57,193 12K 18.4% ▼ 0.4%
UBS Group AG $3,111 1K 1.0% ▲ 93.0%
Morgan Stanley $1,318 0K 0.4% ▼ 35.6%
Rhumbline Advisers $744 0K 0.2% 0.0%
Group One Trading LLC $250 0K 0.1% 0.0%
Jpmorgan Chase & Co $212 0K 0.1% 0.0%
Allworth Financial LP $172 0K 0.1% New

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not The9 LTD's complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart

No open-market insider trades reported in the last 12 months.

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Recent SEC filings

Data status

When each part of this page on The9 LTD was last updated.

DataLast updatedSource
Share priceExchange closing prices
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

The9 LTD in brief

What does The9 LTD do?
The9 LTD is a US-listed company in the investment banking & brokerage industry. Its financial year ends in December.
What is The9 LTD's stock ticker?
The9 LTD trades under the ticker NCTY on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is The9 LTD's revenue, and how fast is it growing?
Over its most recent trailing twelve months, The9 LTD reported revenue of $15M, 3.3% lower than a year earlier, according to its SEC filings.
Who are The9 LTD's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Citadel Advisors LLC, HRT Financial LP and Independent Advisor Alliance. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Who are The9 LTD's competitors?
In our Investment Banking & Brokerage peer group, the companies closest to The9 LTD are Argo Blockchain plc, Waton Financial Ltd, Lion Group Holding Ltd, Solowin Holdings, Ltd. and Garden Stage Ltd. The side-by-side comparison below sets their revenue, margins and growth against The9 LTD's.